Cytokinetics (CYTK) PT Raised to $75 at JPMorgan on Favorable Near-Term Outlook
Tweet Send to a Friend
(Updated - March 17, 2026 7:10 AM EDT)
JPMorgan analyst Tessa Romero raised the price target on Cytokinetics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Tessa Romero raised the price target on Cytokinetics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
